Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
Yahoo Finance · 1 day ago
Open | 43.97 |
High | 44.47 |
Low | 43.73 |
Mkt Cap | 89.62B |
P/E (TTM) | N/A |
Div & Yield | 2.40 & 5.46% |
Prev. Close | 43.94 |
52 Wk. Low | 43.73 |
52 Wk. High | 69.10 |
Related stocks
American pharmaceutical company
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 11.87B | 4.70% ▲ |
Net Income | -11.91B | - |
Diluted EPS | -4.11 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.70 | - |
Q1 2024 | -$4.14 | -$4.11 |
Q4 2023 | $1.43 | $1.59 |
S&P 500^GSPC | 5,018.39-17.30 (-0.34%) |
Dow 30^DJI | 37,903.29+87.37 (+0.23%) |
Nasdaq^IXIC | 15,605.48-52.34 (-0.33%) |
164.11-1.05% | |
Carvana Co.CVNA | 87.09+5.03% |
56.31-16.84% |